The presence of excess weight or obesity in long COVID is significantly associated with neurological and neuropsychiatric symptom development.

The FDA has approved Sephience for the treatment of HPA in adult and pediatric patients 1 month of age and older with sepiapterin-responsive PKU.

(HealthDay News) — Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology.

HealthDay News — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

Individuals with social risk factors at the time of SARS-CoV-2 infection have increased risk for subsequent long COVID.

Adolescents who use tobacco products are significantly more likely to report symptoms of depression and anxiety than teens who do not use tobacco products.

Among patients with T2D and DPN, some with nonpainful DPN developed neuropathic pain over a 5-year period while others with painful DPN experienced relief.